Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

被引：0

作者：

O Benjamini

M Koren-Michowitz

N Amariglio

N Kroger

A Nagler

A Shimoni

机构：

[1] Chaim Sheba Medical Center,Division of Hematology and Bone Marrow Transplantation

来源：

Leukemia | 2008年 / 22卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1961 / 1963

页数：2

共 50 条

[31] MINIMAL RESIDUAL DISEASE MONITORING BY DIGITAL PCR FOR JAK2V617F DETECTION IN PATIENTS WITH MYELOFIBROSIS (MF) OR ACUTE MYELOID LEUKEMIA SECONDARY TO MF AFTER ALLOGENEIC STEM CELL TRANSPLANTATION [J].

Salmoiraghi, S. ;

Belotti, C. ;

Finazzi, M. C. ;

Mico, M. C. ;

Algarotti, A. ;

Finazzi, G. ;

Mascheroni, M. ;

Salvi, A. ;

Rambaldi, A. ;

Spinelli, O. .

HAEMATOLOGICA, 2017, 102 :539-540

[32] Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms [J].

Haslam, Karl ;

Molloy, Karen M. ;

Conneally, Eibhlin ;

Langabeer, Stephen E. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) :E29-E31

[33] What is the impact of JAK2-V617F mutation and its gene load on the progression of myelofibrosis after hematopoietic stem cell graft [J].

Suarez, Felipe .

HEMATOLOGIE, 2011, 17 (01) :10-11

[34] Utility of JAK2V617F and MPLW515L/K mutation analysis in the setting of allogeniec stem cell transplantation for myelofibrosis [J].

Alchalby, H. ;

Badbaran, A. ;

Kobbe, G. ;

Hahn, J. ;

Wolff, D. ;

Bornhaeuser, M. ;

Baurmann, H. ;

Bock, O. ;

Bethge, W. ;

Bacher, U. ;

Fehse, B. ;

Zander, A. R. ;

N, Kroeger .

ONKOLOGIE, 2010, 33 :26-26

[35] The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage:: a case of human allogeneic transplantation [J].

Van Pelt, Kristien ;

Nollet, Friedel ;

Seileslag, Dominik ;

Knoops, Laurent ;

Constantinescu, Stefan N. ;

Criel, Arnold ;

Billiet, Johan .

BLOOD, 2008, 112 (03) :921-922

[36] A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation [J].

Nikiforow, Sarah ;

Kim, Haesook T. ;

Daley, Heather ;

Reynolds, Carol ;

Jones, Kyle Thomas ;

Armand, Philippe ;

Ho, Vincent T. ;

Alyea, Edwin P., III ;

Cutler, Corey S. ;

Ritz, Jerome ;

Antin, Joseph H. ;

Soiffer, Robert J. ;

Koreth, John .

HAEMATOLOGICA, 2016, 101 (10) :1251-1259

[37] Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation [J].

Lee, Jong-Mi ;

Ahn, Ari ;

Min, Eun Jeong ;

Lee, Sung-Eun ;

Kim, Myungshin ;

Kim, Yonggoo .

BLOOD CANCER JOURNAL, 2023, 13 (01)

[38] Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation [J].

Jong-Mi Lee ;

Ari Ahn ;

Eun Jeong Min ;

Sung-Eun Lee ;

Myungshin Kim ;

Yonggoo Kim .

Blood Cancer Journal, 13

[39] Effective treatment with imatinib mesylate and donor lymphocyte infusion following relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. [J].

Li, JY ;

Wu, HX ;

Qian, SX ;

Hong, M ;

Xiao, B ;

Zhang, R ;

Ruan, CG .

BLOOD, 2005, 106 (11) :441B-441B

[40] FACTORS AFFECTING SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA WHO RECEIVED DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF FIRST RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION [J].

Kurnaz, F. ;

Kaynar, L. ;

Eser, B. ;

Altuntas, F. ;

Sivgin, S. ;

Pala, C. ;

Sahin, C. ;

Unal, A. ;

Cetin, M. .

HAEMATOLOGICA, 2015, 100 :606-606

← 1 2 3 4 5 →